A U.S. study revealed that administering topical or injected versions of a synthetic compound called CP-31398 helps treat the damage in the tumor-suppressing p53 gene in mice exposed to ultraviolet B rays, leading to the prevention of skin cancer development and inhibition of tumor growth in mice. Research on the compound could lead to development of a more-effective cream or sunblock designed to protect against skin cancer, a doctor said.

Related Summaries